Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong
· Delayed Price · Currency is HKD 459.80
-9.40 (-2.00%)
At close: Apr 29, 2026
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 109.41 billion as of April 29, 2026. Its market cap has increased by 54.60% in one year.
Market Cap
109.41B
Enterprise Value
104.53B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
459.80
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 109.41B, an increase of 711.09%. That is a compound annual growth rate of 111.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 113.26B | 23.85% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 126.47B |
| Sino Biopharmaceutical | 98.99B |
| WuXi Biologics | 137.71B |
| Innovent Biologics | 148.88B |
| RemeGen | 76.50B |
| 3SBio | 55.35B |
| BeOne Medicines AG | 261.35B |
| Biocytogen Pharmaceuticals (Beijing) | 44.62B |